ADVIA CENTAUR XP SYPHILIS N/A 10492493

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-06-09 for ADVIA CENTAUR XP SYPHILIS N/A 10492493 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[77619183] The cause for the discordant (b)(6) results is unknown. The patient sample is not available for additional testing at the manufacturer's site. Siemens healthcare diagnostics is unable to determine root cause. The appears to be a sample specific issue. The interpretation of results section of the instructions for use (ifu) state: "results should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings. " the limitations section of the ifu states: "a nonreactive test result does not exclude the possibility of exposure to or infection with syphilis. T. Pallidum antibodies may be undetectable in some stages of the infection and in some clinical conditions. Assay performance characteristics have not been established when the advia centaur syph assay is used in conjunction with other manufacturers' assays for specific syphilis serological markers. " the advia centaur syphilis (syph) ifu (10632392 rev. F, 2016-04 ous) states "the initial sensitivity of the advia centaur syph assay compared to reference assay 1 was 98. 0% (700/714) with a 95% confidence interval of 96. 7-98. 9%. The advia centaur syphilis (syph) ifu (10632391 rev. F, 2016-04 us) states "the negative percent agreement of the advia centaur syph assay compared to the comparative assay was 98. 4% (568/577) with a 95% confidence interval (ci) of 97. 1 to 99. 3%. "
Patient Sequence No: 1, Text Type: N, H10


[77619184] Customer observed a (b)(6) advia centaur xp (b)(6) result for a sample that was (b)(6) by other methods. There are not reports that treatment was altered or prescribed or adverse health consequences due to the (b)(6) advia centaur xp (b)(6) result.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2017-00140
MDR Report Key6631081
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-06-09
Date of Report2017-06-09
Date of Event2017-05-14
Date Mfgr Received2017-05-24
Device Manufacturer Date2016-09-09
Date Added to Maude2017-06-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLOUISE MCLAUGHLIN
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604381
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionIN
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP SYPHILIS
Generic NameSYPHILIS ASSAY
Product CodeLIP
Date Received2017-06-09
Model NumberN/A
Catalog Number10492493
Lot Number11095033
Device Expiration Date2017-09-09
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer AddressTARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2017-06-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.